Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Comprehensive Metabolic Panel (CMP) Testing Market, By Disease (Kidney Disease, Liver Disease, Diabetes, Others), Test Type (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose), End-User (Laboratories, PoC) – Industry Trends and Forecast to 2030.
Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Size
The International Diabetes Foundation and the American Diabetes Association are two of the most prominent organizations emphasizing the critical importance of diagnosing and monitoring diabetes through various awareness campaigns and other forms of advertising. Furthermore, the landscape of medical diagnostics has undergone a fundamental shift in recent years, owing to the introduction of improved diagnostic products and biomarkers. However, disease recurrence and progression remain high, particularly among geriatric patients. Strong unmet demands present a significant opportunity in the CMP testing room to develop first-rate breakthrough diagnostics.
Data Bridge Market Research analyses that the comprehensive metabolic panel (CMP) testing market which was USD 14.77 billion in 2022, is expected to reach USD 27.95 billion by 2030, at a CAGR of 8.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Comprehensive Metabolic Panel (CMP) Testing Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Disease (Kidney Disease, Liver Disease, Diabetes, Others), Test Type (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose), End-User (Laboratories, PoC) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Walk-In Lab, LLC (U.S.), Abbott (U.S.), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), Healthcare Limited (Australia), Unipath (India), Synlab Group (Germany), Abaxis (U.S.), TCG, Inc. (U.S.), Scion Lab Services, LLC (U.S.) and CENTOGENE N.V. (Germany) |
|
Market Opportunities |
|
Market Definition
A comprehensive metabolic panel is a type of assessment designed to assist doctors in providing information about the body's fluid balance, kidney and liver function, and electrolyte levels. For this test, blood is usually drawn from a vein. It includes electrolytes, protein, kidney function, and liver function tests. It also aids in the tracking of disease symptoms and the side effects of drugs used in disease treatment.
Comprehensive Metabolic Panel (CMP) Testing Market Dynamics
Drivers
- Rising healthcare Industry
The healthcare industry is heavily dependent on regulatory frameworks established by organizations such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency in Europe (EMA). Clinical Laboratory Improvement Amendments (CLIA) regulate the approval of these tests, and government bodies set the fee waiver as well as Medicare and Medicaid reimbursement. The FDA has authority over Laboratory-Developed Tests (LDTs), tests developed in-house in clinical laboratories to provide efficient and rapid results. These are the certain factors which boots the market growth.
Opportunities
- Rising CMP testing
One of the major factors expected to drive the market for CMP testing is rising consumer awareness about healthcare. Many organizations around the world are working to raise awareness about diseases, available treatment options, and the advantages of early diagnosis and precautions. The International Diabetes Foundation and the American Diabetes Association, for example, are two key organizations that emphasize the critical importance of diagnosing and monitoring diabetes through various awareness campaigns and other forms of advertising.
Restraints/Challenges
- Lack of physical activity
A lack of physical activity among the population will accelerate market growth. On the other hand, the ambiguous regulatory system, is expected to hamper the growth of the comprehensive metabolic panel (CMP) market in the coming years.
This comprehensive metabolic panel (CMP) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the comprehensive metabolic panel (CMP) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Comprehensive Metabolic Panel (CMP) Testing Market Scope
The comprehensive metabolic panel (CMP) testing market is segmented on the basis of disease, test type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease
- Kidney Disease
- Liver Disease
- Diabetes
- Others
Test Type
- Proteins
- Electrolytes
- Kidney Tests
- Liver Functional Tests
- Glucose
End-User
- Laboratories
- PoC
Comprehensive Metabolic Panel (CMP) Testing Market Regional Analysis/Insights
The comprehensive metabolic panel (CMP) testing market is analyzed and market size insights and trends are provided by country, disease, test type and end-user as referenced above.
The countries covered in the comprehensive metabolic panel (CMP) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the comprehensive metabolic panel (CMP) testing market because of the rising public awareness about comprehensive metabolic panel and kidney diseases and the increasing geriatric population in the region in the coming years.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing demand for comprehensive metabolic panel testing in the region during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The comprehensive metabolic panel (CMP) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for comprehensive metabolic panel (CMP) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the comprehensive metabolic panel (CMP) testing market. The data is available for historic period 2011-2021.
Competitive Landscape and Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis
The comprehensive metabolic panel (CMP) testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to comprehensive metabolic panel (CMP) testing market.
Some of the major players operating in the comprehensive metabolic panel (CMP) testing market are:
- Walk-In Lab, LLC (U.S.)
- Abbott (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Unipath (India)
- Synlab Group (Germany)
- Abaxis (U.S.)
- TCG, Inc. (U.S.)
- Scion Lab Services, LLC (U.S.)
- CENTOGENE N.V. (Germany)
SKU-
